Joseph Samuel Berman, MD | |
1211 Wilmington Ave, New Castle, PA 16105-2516 | |
(310) 903-6201 | |
Not Available |
Full Name | Joseph Samuel Berman |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 6 Years |
Location | 1211 Wilmington Ave, New Castle, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184117897 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 4301115361 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Twin Cities Community Hospital | Templeton, CA | Hospital |
Sierra Vista Regional Medical Center | San luis obispo, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Coast Emergency Physicians | 9234114067 | 22 |
News Archive
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announces that it has entered into a settlement agreement with Shimadzu Corporation and its wholly owned subsidiary Shimadzu Scientific Instruments, Inc., resolving a lawsuit filed by Caliper in the United States District Court for the Eastern District of Texas that claimed that Shimadzu's MultiNA microchip-based electrophoresis system infringed several U.S. patents relating to Caliper's microfluidic LabChip® technology.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
University of Louisville researchers have replicated the inflammatory gene changes of a human kidney as it progresses from mild to severe diabetic nephropathy, using a mouse model developed by a UofL researcher, according to an article published today in the journal Experimental Nephrology. Diabetic nephropathy is the foremost cause of kidney failure.
An estimated 207,090 women in the U.S. will be diagnosed with breast cancer this year alone, according to the American Cancer Society. While a diagnosis undoubtedly creates a frightening experience for any family, the more that information is available about the disease, the less upsetting it can be. Naturally, patients will look beyond what is provided by their attending physician, but where can they go when they have specific health questions?
David Griggs, Ph.D., director of biology at Saint Louis University's Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to treat bone diseases.
› Verified 2 days ago
Entity Name | Central Coast Emergency Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972535557 PECOS PAC ID: 9234114067 Enrollment ID: O20040623001681 |
News Archive
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announces that it has entered into a settlement agreement with Shimadzu Corporation and its wholly owned subsidiary Shimadzu Scientific Instruments, Inc., resolving a lawsuit filed by Caliper in the United States District Court for the Eastern District of Texas that claimed that Shimadzu's MultiNA microchip-based electrophoresis system infringed several U.S. patents relating to Caliper's microfluidic LabChip® technology.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
University of Louisville researchers have replicated the inflammatory gene changes of a human kidney as it progresses from mild to severe diabetic nephropathy, using a mouse model developed by a UofL researcher, according to an article published today in the journal Experimental Nephrology. Diabetic nephropathy is the foremost cause of kidney failure.
An estimated 207,090 women in the U.S. will be diagnosed with breast cancer this year alone, according to the American Cancer Society. While a diagnosis undoubtedly creates a frightening experience for any family, the more that information is available about the disease, the less upsetting it can be. Naturally, patients will look beyond what is provided by their attending physician, but where can they go when they have specific health questions?
David Griggs, Ph.D., director of biology at Saint Louis University's Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to treat bone diseases.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Joseph Samuel Berman, MD 3611 Penn Ave Apt 2, Pittsburgh, PA 15201-1334 Ph: (310) 903-6201 | Joseph Samuel Berman, MD 1211 Wilmington Ave, New Castle, PA 16105-2516 Ph: (310) 903-6201 |
News Archive
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announces that it has entered into a settlement agreement with Shimadzu Corporation and its wholly owned subsidiary Shimadzu Scientific Instruments, Inc., resolving a lawsuit filed by Caliper in the United States District Court for the Eastern District of Texas that claimed that Shimadzu's MultiNA microchip-based electrophoresis system infringed several U.S. patents relating to Caliper's microfluidic LabChip® technology.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
University of Louisville researchers have replicated the inflammatory gene changes of a human kidney as it progresses from mild to severe diabetic nephropathy, using a mouse model developed by a UofL researcher, according to an article published today in the journal Experimental Nephrology. Diabetic nephropathy is the foremost cause of kidney failure.
An estimated 207,090 women in the U.S. will be diagnosed with breast cancer this year alone, according to the American Cancer Society. While a diagnosis undoubtedly creates a frightening experience for any family, the more that information is available about the disease, the less upsetting it can be. Naturally, patients will look beyond what is provided by their attending physician, but where can they go when they have specific health questions?
David Griggs, Ph.D., director of biology at Saint Louis University's Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to treat bone diseases.
› Verified 2 days ago
Dr. Casey John Jason, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1211 Wilmington Ave, New Castle, PA 16105 Phone: 724-658-9001 | |
James Gordon Gregory, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3131 Wilmington Rd, New Castle, PA 16105 Phone: 724-652-3505 Fax: 866-588-2705 | |
Alexandra Kae Lawler, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1211 Wilmington Ave, New Castle, PA 16105 Phone: 724-658-9001 |